期刊文献+

On-line血液透析滤过对维持性血液透析患者心率变异性的影响 被引量:5

The effect of on-line hemodiafiltration on heart rate variability in maintenance hemodialysis patients
下载PDF
导出
摘要 目的探讨On-line血液透析滤过技术对维持性血液透析患者心率变异性(HRV)的影响。方法 50例维持性血液透析(MHD)患者随机分为常规血液透析治疗组(HD组)和On-line血液透析滤过治疗组(OL-HDF组),每组各25例。患者每周行3次、每次4 h的血液透析治疗或OL-HDF,治疗24个月。比较两组常规的实验室检查和24h动态心电图监测结果。结果治疗24个月后,OL-HDF组的β2-微球蛋白(β2-MG)由基线值30.1±7.2 mg/dl降至21.7±6.1 mg/dl(P<0.05),HD组的β2-MG则无明显下降。OL-HDF组HRV的时域性和频域性指标均值高于基线值(P<0.05),HD组的HRV指标则无显著性变化(P>0.05)。结论与普通血液透析比较,OL-HDF能更好地改善MHD患者的HRV,改善自主神经功能。 Objective To investigate the effects of On - 1 ine hemodiafiltration on heart rate viability of maintenance hemodialysis (MHD) patients. Methods Fifty chronic HD patients were divided into conventional HD and OL - HDF groups. They received regular high - flux HD or OL - HDF for4 - hour sessions, three times a week. Time - and frequency - domain measures of the 24 h HRV were analyzed every 6 months for 24 months. Routine laboratory tests and the parameter of 24 h Holter monitoring electrocardiogram were compared between the two groups. Results There was no difference in the baseline characteristics. After 24 months of treatment, {32 - microglobulin concentration decreased (from 30.1± 7.2 mg/dl to 21.7 ± 6.1 mg/dl, P 〈 0.05 ) in the OL - HDF group, while there was no change in the HD group. In the HRV analysis, Time - and frequency - domain HRV parameters increased significantly compared with base line in the OL - HDF group natural ( P 〈 0.05 ). However, there was no change in the HD group ( P 〉 O. 05 ). Conclusion This study shows that OL - HDF improved autonomic nervous system dysfunc- tion compared with HD group in chronic HD patients.
出处 《临床和实验医学杂志》 2017年第17期1761-1764,共4页 Journal of Clinical and Experimental Medicine
关键词 维持性血液透析 On-line血液透析滤过心率变异性 Maintenance hemodialysis On -line hemodiafiltration Heart rate variability
  • 相关文献

参考文献4

二级参考文献59

  • 1刘斌,林家弟,李霞,李露,卜佳.血液透析治疗尿毒症者心率变异性与心律失常关系的探讨[J].实用心电学杂志,2010,19(3):171-172. 被引量:5
  • 2于学清.最新血液透析并发症防范处理技术与临床透析治疗^实践及血液透析中心标准化管理规章制度[M].北京:人民军医科技出版社,2009.
  • 3Burmeister JE, Scapini A, da Rosa Miltersteiner D,et al. Glu-cose-added dialysis fluid prevents asymptomatic hypoglycaemia inregular haemodialysis [ J ]. Nephrol Dial Transplant,2007 , 22(6):1184-1189.
  • 4Levy j, Morgan J, Brown E.牛津临床透析手册[M].王梅,王悦,崔太根,等,译.第2版.北京:人民卫生出版社,2006.
  • 5Sharma R, Rosner MH. Glucose in the dialysate: historical per-spective and possible implications[ J]. Hemodial Int, 2008, 12(4) :221-226.
  • 6Salameh E,Mallat S,Hamdan R,ei al. Heart rate variability alter-ation in patients on chronic hemodialysis [ J ]. Ann Cardiol Angeiol(Paris), 2009,58(1) :7-10.
  • 7Block GA,Wheeler DC,Persky MS,et al.Effects of phosphate binders in moderate CKD[J].J Am Soc Nephrol,2012,23:1407-1415.
  • 8Tentori F,Blayney MJ,Albert JM,et al.Mortality risk for dialysis patients with different levels of serum calcium,phosphorus,and PTH:the Dialysis Outcomes and Practice Patterns Study (DOPPS)[J].Am J Kidney Dis,2008,52:519-530.
  • 9Raggi P,Vukicevie S,Moyses RM,et al.Ten year experence with sevelamer and calcium salts as phosphate binders[J].Clin J Am Soc Nephrol,2010,5:S31-40.
  • 10Improving Global Outcome (KDIGO) CKD-MBD Work Group.KDIGO clinical practice guideline for the diagnosis evaluation,prevention and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)[J].Kidney Int Suppl,2009,113:S1-130.

共引文献20

同被引文献54

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部